Taken together, the above in vivo and in vitro results confirmed that TNFR2+CCR8+ Tregs played crucial roles in inhibiting CD8+ T cell function and infiltration in the TME, thereby promoting tumour growth. Here, TNFRSF1B is linked to neoplasm.